Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
Paul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Maria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal
|
June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Giuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
Journal of Hypertension
|
December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
Jasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 6, 2024
[2024 ESC Guidelines for the management of elevated blood pressure and hypertension]
John William McEvoy, Cian P McCarthy, Rosa Maria Bruno, et al.
European Heart Journal
|
August 30, 2024
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John William McEvoy, Cian P McCarthy, Rosa Maria Bruno, et al.
European Journal of Heart Failure
|
April 14, 2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
European Journal of Heart Failure
|
June 22, 2016
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
European Journal of Heart Failure
|
January 27, 2022
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
Massimo F Piepoli, Marianna Adamo, Andrea Barison, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
Paul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Maria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal
|
June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Giuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
Journal of Hypertension
|
December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
Jasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 6, 2024
[2024 ESC Guidelines for the management of elevated blood pressure and hypertension]
John William McEvoy, Cian P McCarthy, Rosa Maria Bruno, et al.
European Heart Journal
|
August 30, 2024
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John William McEvoy, Cian P McCarthy, Rosa Maria Bruno, et al.
European Journal of Heart Failure
|
April 14, 2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
European Journal of Heart Failure
|
June 22, 2016
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
European Journal of Heart Failure
|
January 27, 2022
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
Massimo F Piepoli, Marianna Adamo, Andrea Barison, et al.
Page
of 8